
Insights from recent episode analysis
Audience Interest
Podcast Focus
Publishing Consistency
Platform Reach
Insights are generated by CastFox AI using publicly available data, episode content, and proprietary models.
Most discussed topics
Brands & references
Total monthly reach
Estimated from 8 chart positions in 8 markets.
By chart position
- 🇮🇳IN · Medicine#8510K to 30K
- 🇲🇽MX · Medicine#1181K to 10K
- 🇰🇷KR · Medicine#1631K to 10K
- 🇧🇷BR · Medicine#1971K to 10K
- 🇹🇭TH · Medicine#102500 to 3K
- Per-Episode Audience
Est. listeners per new episode within ~30 days
7.5K to 36K🎙 ~2x weekly·127 episodes·Last published 2w ago - Monthly Reach
Unique listeners across all episodes (30 days)
15K to 72K🇮🇳42%🇲🇽14%🇰🇷14%+5 more - Active Followers
Loyal subscribers who consistently listen
6K to 29K
Market Insights
Platform Distribution
Reach across major podcast platforms, updated hourly
Total Followers
—
Total Plays
—
Total Reviews
—
* Data sourced directly from platform APIs and aggregated hourly across all major podcast directories.
On the show
From 10 epsHosts
Recent guests
Recent episodes
Population Skin Cancer Screening and Melanoma Mortality Rates
Jun 10, 2026
Unknown duration
Limits of Artificial Intelligence Models for Skin Cancer Diagnosis in Realistic Settings
Jun 3, 2026
Unknown duration
Skin Cancer Risk Profiles in Patients Seen for Periodic Skin Examinations
May 20, 2026
Unknown duration
Consumer Understanding of Skin Concerns With an AI-Powered Informational Tool
Apr 15, 2026
18m 59s
A Pigment-Informed Dermatology Framework—Reimagining "Skin of Color"
Mar 18, 2026
20m 12s
Social Links & Contact
Official channels & resources
Official Website
Login
RSS Feed
Login
| Date | Episode | Topics | Guests | Brands | Places | Keywords | Sponsor | Length | |
|---|---|---|---|---|---|---|---|---|---|
| 6/10/26 | Population Skin Cancer Screening and Melanoma Mortality Rates | Interview with Joachim Hübner, MD, SJD, and Alexander Katalinic, MD, authors of Population Skin Cancer Screening and Melanoma Mortality Rates. Hosted by Adewole S. Adamson, MD, MPP. Related Content: Population Skin Cancer Screening and Melanoma Mortality Rates | — | ||||||
| 6/3/26 | Limits of Artificial Intelligence Models for Skin Cancer Diagnosis in Realistic Settings | Interview with Luc Thomas, MD, PhD, author of Limits of Artificial Intelligence Models for Skin Cancer Diagnosis in Realistic Settings. Hosted by Adewole S. Adamson, MD, MPP. Related Content: Limits of Artificial Intelligence Models for Skin Cancer Diagnosis in Realistic Settings | — | ||||||
| 5/20/26 | Skin Cancer Risk Profiles in Patients Seen for Periodic Skin Examinations | Interview with Robert A. Swerlick, MD, author of Skin Cancer Risk Profile of Asymptomatic Patients Seeking Periodic Skin Examinations for Skin Cancer Concerns. Hosted by Adewole S. Adamson, MD, MPP. Related Content: Skin Cancer Risk Profile of Asymptomatic Patients Seeking Periodic Skin Examinations for Skin Cancer Concerns | — | ||||||
| 4/15/26 | Consumer Understanding of Skin Concerns With an AI-Powered Informational Tool✨ | skin concernsAI-powered tools+3 | Rory Sayres, PhD | JAMA Network | — | skin concernsAI+5 | — | 18m 59s | |
| 3/18/26 | A Pigment-Informed Dermatology Framework—Reimagining "Skin of Color"✨ | dermatologyskin of color+3 | Rashmi Sarkar, MD | A Pigment-Informed Dermatology Framework—Reimagining 'Skin of Color' | — | dermatologyskin of color+5 | — | 20m 12s | |
| 2/18/26 | Sunscreen Costs in Association With Sun Protective Behaviors✨ | sunscreensun protective behaviors+3 | Maria L. Wei, MD, PhD | Sunscreen Costs in Association With Sun Protective Behaviors | — | sunscreen costssun protection+3 | — | 16m 29s | |
| 1/21/26 | Discordance in Treatment Response Assessment Between Clinicians and Patients With Skin Chronic GVHD✨ | treatment response assessmentchronic graft-vs-host disease+3 | Emily Baumrin, MD, MSCE | Discordance in Treatment Response Assessment Between Clinicians and Patients With Skin Chronic Graft-vs-Host Disease | — | chronic GVHDtreatment response+3 | — | 21m 02s | |
| 1/14/26 | Advanced Practice Clinicians and Dermatology Drug Spending✨ | dermatologydrug spending+3 | Arash Mostaghimi, MD, MPA, MPH | Advanced Practice Clinicians and Dermatology Drug SpendingBiologics Prescribing in Dermatology by Advanced Practice Clinicians—Trends in the Practice of Advanced Practice Clinicians in Dermatology | — | dermatologydrug spending+3 | — | 22m 07s | |
| 11/12/25 | Recovering From Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis✨ | Stevens-Johnson SyndromeToxic Epidermal Necrolysis+3 | Elizabeth J. Phillips, MD | Recovering From Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis | — | Stevens-Johnson SyndromeToxic Epidermal Necrolysis+3 | — | 21m 18s | |
| 10/15/25 | Skin Cancer Surveillance Program for Solid Organ Transplant Recipients✨ | skin cancersolid organ transplant+3 | David S. Lee, MD | JAMA NetworkSkin Cancer Surveillance Program for Solid Organ Transplant Recipients | — | skin cancertransplant recipients+3 | — | 16m 58s | |
Want analysis for the episodes below?Free for Pro Submit a request, we'll have your selected episodes analyzed within an hour. Free, at no cost to you, for Pro users. | |||||||||
| 9/17/25 | Nicotinamide for Skin Cancer Chemoprevention✨ | skin cancerchemoprevention+3 | Lee Wheless, MD, PhD | Nicotinamide for Skin Cancer ChemopreventionNicotinamide for Skin Cancer Chemoprevention (Original Investigation)+1 | — | nicotinamideskin cancer+3 | — | 22m 11s | |
| 9/10/25 | A Risk Prediction Tool for Invasive Melanoma✨ | melanomarisk prediction+3 | David C. Whiteman, MBBS, PhD | A Risk Prediction Tool for Invasive Melanoma | — | melanomarisk prediction tool+3 | — | 22m 22s | |
| 7/23/25 | Emollients to Prevent Pediatric Eczema✨ | pediatric eczemaemollients+3 | Eric L. Simpson, MD, MCR | Emollients to Prevent Pediatric Eczema: A Randomized Clinical TrialEmollients to Prevent Atopic Dermatitis—Is New Evidence a Game Changer? | — | pediatric eczemaemollients+5 | — | 23m 24s | |
| 6/18/25 | Defining On-Treatment Remission in Plaque Psoriasis | Interview with April W. Armstrong, MD, MPH, author of Defining On-Treatment Remission in Plaque Psoriasis: A Consensus Statement From the National Psoriasis Foundation. Hosted by Adewole S. Adamson, MD. Related Content: Defining On-Treatment Remission in Plaque Psoriasis | — | ||||||
| 5/28/25 | How to Publish a Research Paper in a High-Impact Dermatology Journal—A Primer for Trainees | Interview with Andrea D. Maderal, MD, author of How to Publish a Research Paper in a High-Impact Dermatology Journal. Hosted by Adewole S. Adamson, MD. Related Content: How to Publish a Research Paper in a High-Impact Dermatology Journal | — | ||||||
| 4/16/25 | Use of and Cost of First-Line Biologics to Treat Plaque Psoriasis in the US | Interview with Benjamin N. Rome, MD, MPH, author of Use and Cost of First-Line Biologics to Treat Plaque Psoriasis in the US: Use of and Cost of First-Line Biologics to Treat Plaque Psoriasis in the US. Hosted byAdewole S. Adamson, MD. Related Content: Use and Cost of First-Line Biologic Medications to Treat Plaque Psoriasis in the US | — | ||||||
| 3/26/25 | 3D Total-Body Photography in Patients at High Risk for Melanoma | Interview with Monika Janda, PhD, author of 3D Total-Body Photography in Patients at High Risk for Melanoma: A Randomized Clinical Trial. Hosted by Adewole S. Adamson, MD. Related Content: 3D Total-Body Photography in Patients at High Risk for Melanoma | — | ||||||
| 2/12/25 | The Role of Formulation in Benzene Formation in Benzoyl Peroxide Products | Interview with John S. Barbieri, MD, MBA, and Michelle Wong, PhD, authors of The Role of Formulation in Benzene Formation in Benzoyl Peroxide Products. Hosted by Adewole S. Adamson, MD. Related Content: The Role of Formulation in Benzene Formation in Benzoyl Peroxide Products | — | ||||||
| 1/29/25 | Superficial Curettage Plus Imiquimod Cream for Nodular Basal Cell Carcinoma | Interview with Babette J. A. Verkouteren, MD, PhD, author of Imiquimod Cream Preceded by Superficial Curettage vs Surgical Excision for Nodular Basal Cell Carcinoma: A Secondary Analysis of a Randomized Clinical Trial. Hosted by Adewole S. Adamson, MD. Related Content: Imiquimod Cream Preceded by Superficial Curettage vs Surgical Excision for Nodular Basal Cell Carcinoma | — | ||||||
| 12/23/24 | Outpatient Dermatology Productivity Measures by Patient Race, Sex, and Age | Interview with Lauren A. V. Orenstein, MD, MSc, author of Outpatient Dermatology Productivity Measures by Patient Race, Sex, and Age. Hosted by Adewole S. Adamson, MD. Related Content: Outpatient Dermatology Productivity Measures by Patient Race, Sex, and Age | — | ||||||
| 10/16/24 | Hidradenitis Suppurativa and Maternal and Offspring Outcomes | Interview with Nathalie Auger, MD, MSc, and Vincent Piguet, MD, PhD, authors of Hidradenitis Suppurativa and Maternal and Offspring Outcomes. Hosted by Adewole S. Adamson, MD. Related Content: Hidradenitis Suppurativa and Maternal and Offspring Outcomes | — | ||||||
| 9/25/24 | Global Antimicrobial Susceptibility Patterns of Staphylococcus aureus in Atopic Dermatitis | Interview with Maria Teresa García-Romero, MD, MPH, author of Global Antimicrobial Susceptibility Patterns of Staphylococcus aureus in Atopic Dermatitis: A Systematic Review and Meta-Analysis. Hosted by Adewole S. Adamson, MD. Related Content: Global Antimicrobial Susceptibility Patterns of Staphylococcus aureus in Atopic Dermatitis | — | ||||||
| 9/25/24 | Home- vs Office-Based Narrowband UV-B Phototherapy for Patients With Psoriasis | Interview with Joel M. Gelfand, MD, author of Home- vs Office-Based Narrowband UV-B Phototherapy for Patients With Psoriasis: The LITE Randomized Clinical Trial. Hosted by Adewole S. Adamson, MD. Related Content: Home- vs Office-Based Narrowband UV-B Phototherapy for Patients With Psoriasis | — | ||||||
| 8/28/24 | Cutaneous Neurofibromas and Quality of Life in Adults With Neurofibromatosis Type 1 | Interview with Kavita Y. Sarin, MD, PhD, author of Cutaneous Neurofibromas and Quality of Life in Adults With Neurofibromatosis Type 1. Hosted by Adewole S. Adamson, MD, MPP. Related Content: Cutaneous Neurofibromas and Quality of Life in Adults With Neurofibromatosis Type 1 | — | ||||||
| 7/24/24 | Standardizing Retrospective Observational Research in Cutaneous Squamous Cell Carcinoma | Interview with Kathryn T. Shahwan, MD, author of Standardizing Retrospective Observational Research in Cutaneous Squamous Cell Carcinoma: Expert Panel Guidelines from ITSCC. Hosted by Adewole S. Adamson, MD, MPP. Related Content: Standardizing Retrospective Observational Research in Cutaneous Squamous Cell Carcinoma | — | ||||||
Showing 25 of 130
Sponsor Intelligence
Sign in to see which brands sponsor this podcast, their ad offers, and promo codes.
Chart Positions
8 placements across 8 markets.
Chart Positions
8 placements across 8 markets.
